Background The BRCA1-associated protein-1 (BAP1) tumor predisposition syndrome (BAP1- TPDS) is a hereditary tumor syndrome caused by germline pathogenic variants in BAP1 …
F Baumann, E Flores, A Napolitano, S Kanodia… - …, 2015 - academic.oup.com
Abstract BRCA1-associated protein-1 (BAP1) mutations cause a new cancer syndrome, with a high rate of malignant mesothelioma (MM). Here, we tested the hypothesis that MM …
K Rai, R Pilarski, CM Cebulla… - Clinical …, 2016 - Wiley Online Library
The BRCA1‐associated protein‐1 (BAP1) tumor predisposition syndrome (BAP1‐TPDS) is a recently identified hereditary cancer syndrome. Germline mutations in this tumor suppressor …
Twenty years ago, the first familial melanoma susceptibility gene, CDKN 2A, was identified. Two years later, another high‐penetrance gene, CDK 4, was found to be responsible for …
AM Haugh, CN Njauw, JA Bubley, AE Verzì… - JAMA …, 2017 - jamanetwork.com
Importance Patients with germline mutations inBAP1may develop several flesh-colored melanocyticBAP1–mutated atypical intradermal tumors (MBAITs). These tumors generally …
SM McGregor, R Dunning, E Hyjek, W Vigneswaran… - Human Pathology, 2015 - Elsevier
Summary BRCA-associated protein 1 (BAP1) has emerged as a promising biomarker for malignant pleural mesothelioma (MPM). Loss of BAP1 expression can occur by a variety of …
L Brcic, I Kern - Translational lung cancer research, 2020 - ncbi.nlm.nih.gov
Malignant mesothelioma (MM) is uncommon, but very aggressive tumor arising from the mesothelial cells of pleura, pericardium, peritoneum, and tunica vaginalis. Despite …
M Betti, A Aspesi, A Biasi, E Casalone, D Ferrante… - Cancer letters, 2016 - Elsevier
BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co …